The Impact of COVID-19 is included in Chickenpox Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Chickenpox Vaccine Trends and Forecast
The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines, and growing government contribution in immunization programs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chickenpox Vaccine by Segment
The study includes a forecast for the global chickenpox vaccine by product type, application, end use, and region.
Chickenpox Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Monovalent Varicella Vaccine
• Combination Varicella Vaccine
Chickenpox Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Mumps
• Measles
• Rubella
• Varicella Immunization
• Herpes Zoster
• Immunization
• Chickenpox Vaccination
Chickenpox Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Clinics
• Others
Chickenpox Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Chickenpox Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-
• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings
Chickenpox Vaccine Market Insights
Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.
Within this market, hospital is expected to witness higher growth over the forecast period.
North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.
Features of the Global Chickenpox Vaccine Market
Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).
Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the chickenpox vaccine market size?
Answer: The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030.
Q.2 What is the growth forecast for chickenpox vaccine market?
Answer: The global chickenpox vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the chickenpox vaccine market?
Answer: The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines and growing government contribution in immunization programs.
Q4. What are the major segments for chickenpox vaccine market?
Answer: The future of the chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets.
Q5. Who are the key chickenpox vaccine market companies?
Answer: Some of the key chickenpox vaccine companies are as follows:
• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings
Q6. Which chickenpox vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.
Q7. In chickenpox vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Chickenpox Vaccine Market, Chickenpox Vaccine Market Size, Chickenpox Vaccine Market Growth, Chickenpox Vaccine Market Analysis, Chickenpox Vaccine Market Report, Chickenpox Vaccine Market Share, Chickenpox Vaccine Market Trends, Chickenpox Vaccine Market Forecast, Chickenpox Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Chickenpox Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Chickenpox Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Chickenpox Vaccine Market by Product Type
3.3.1: Monovalent Varicella Vaccine
3.3.2: Combination Varicella Vaccine
3.4: Global Chickenpox Vaccine Market by Application
3.4.1: Mumps
3.4.2: Measles
3.4.3: Rubella
3.4.4: Varicella Immunization
3.4.5: Herpes Zoster
3.4.6: Immunization
3.4.7: Chickenpox Vaccination
3.5: Global Chickenpox Vaccine Market by End Use
3.5.1: Hospitals
3.5.2: Clinics
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Chickenpox Vaccine Market by Region
4.2: North American Chickenpox Vaccine Market
4.2.1: North American Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
4.2.2: North American Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
4.3: European Chickenpox Vaccine Market
4.3.1: European Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
4.3.2: European Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
4.4: APAC Chickenpox Vaccine Market
4.4.1: APAC Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
4.4.2: APAC Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
4.5: ROW Chickenpox Vaccine Market
4.5.1: ROW Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
4.5.2: ROW Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
6.2: Emerging Trends in the Global Chickenpox Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bio-Med
7.2: GlaxoSmithKline
7.3: Emcure Pharmaceuticals
7.4: Novo Medi Services
7.5: Sanofi
7.6: Takeda Pharmaceutical
7.7: Changchun BCHT Biotechnology
7.8: Green Cross Holdings
7.9: Merck
7.10: Mitsubishi Chemical Holdings
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Chickenpox Vaccine Market Report.